Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and JAMES DETAR

Synopsys Ranks No. 1 Among Software Makers

Synopsys is the No. 1 ranked company in the software group as it continues to report outstanding profit and sales growth. On Tuesday, its stock Relative Strength (RS) Rating, climbed to 85, up from 79 the day before, putting it in a rarefied group. Synopsys stock was up 1.5% Tuesday afternoon.

Synopsys Stock Strength Increasing

The new 85 RS Rating means that Synopsys stock has outperformed 85% of all stocks on price performance over the past year. It's a big leap because market research shows that the best stocks often have an RS Rating north of 80 in the early stages of their moves.

Synopsys makes semiconductor design and manufacturing software and products made on its software are found in virtually all major markets including autos, medical, fintech, manufacturing and government. Its stock climbed about 123% from a Covid market intraday low 104.90 in late March 2020 to around 339 Tuesday.

Among its other crucial ratings, Mountain View, Calif.-based Synopsys boasts a 93 EPS Rating, putting it in the top 7% of companies for recent and long-term profit growth. Additionally it has a 95 Composite Rating and a B+ Accumulation/Distribution Rating, on an A+ to E scale. The B+ rating signifies that analysts are briskly buying Synopsys shares.

Regarding fundamentals, the company has posted rising EPS growth in each of the last two reports. Sales gains have also risen during the same period. Last quarter, Synopsys reported a 58% surge in EPS to $2.40 on 31% higher revenue of $1.27 billion.

Raised Outlook For 2022

On the company's Feb. 16 first quarter earnings call, co-CEO Aart de Geus said, "Synopsys began fiscal year 2022 with excellent momentum, supported by strength across all product groups and geographies." De Geus added the company "delivered financial results at or above guidance targets, returned $250 million to shareholders through stock repurchases, and are raising our outlook for the year."

Looking For Winning Stocks? Try This Simple Routine

Synopsys stock, an IBD 50 list stock, is working on a cup-without-handle pattern with a 377.70 buy point. See if it can clear the breakout price in heavy volume.

Synopsys stock earns the No. 1 rank among its peers in the Computer Software-Design industry group. PDF Solutions and Cadence Design Systems are also among the top five companies in the group.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD's unique RS Rating tracks market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against the rest of the market.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.